Potent antitumor activity through dual targeting of PD-L1 and TGF-{beta} pathways in the glioma tumor microenvironment
Background
Glioblastoma, one of the most aggressive brain tumors, has been largely resistant to conventional immunotherapies, underscoring the need for novel treatment approaches. A promising strategy involves simultaneously inhibiting immunosuppressi…